CyCLE: CyPass Clinical Experience Study

Sponsor
Transcend Medical, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT01097174
Collaborator
(none)
555
14
67
39.6
0.6

Study Details

Study Description

Brief Summary

This study is to evaluate the long-term safety, effectiveness and clinical experience of the CyPass Micro-Stent in patients with glaucoma.

Condition or Disease Intervention/Treatment Phase
  • Device: CyPass Micro-Stent

Study Design

Study Type:
Observational
Actual Enrollment :
555 participants
Observational Model:
Case-Only
Time Perspective:
Other
Official Title:
A Multicenter Registry Study to Capture Data With Respect to CyPass Clinical Experience
Study Start Date :
Dec 1, 2009
Actual Primary Completion Date :
Jul 1, 2015
Actual Study Completion Date :
Jul 1, 2015

Arms and Interventions

Arm Intervention/Treatment
CyPass Micro-stent

Patients in whom CyPass Micro-stent implantation was attempted.

Device: CyPass Micro-Stent
The CyPass Micro-Stent is a small tube with a through-lumen designed to redirect aqueous fluid from the front into the back of they eye.

Outcome Measures

Primary Outcome Measures

  1. Incidence of intraoperative and postoperative adverse events [Day 0 - Year 3]

Secondary Outcome Measures

  1. Intraocular pressure (IOP) reduction [1 - 36 months postoperatively]

  2. Ocular hypotensive medication use [1 - 36 months postoperatively]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of OAG

  • IOP ≥ 21 mmHg and ≤ 31 mmHg (with or without ocular hypotensive medication)

Exclusion Criteria:
  • Acute angle closure, narrow angle, uveitic or neovascular glaucoma

  • Normal tension glaucoma

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Eye Clinic Salzburg Austria
2 Specialized Hospital for Active Treatment of Ophthalmologic Diseases Sofia Bulgaria
3 Schlosspark-Klinik, Department of Ophthalmology Berlin Germany
4 Knappschaftskrankenhaus Bochum-Langendreer Bochum Germany
5 AugenKlinik Cham Cham Germany
6 Klinik fur Augenheilkunde, Campus Lubeck Lubeck Germany
7 Klinik für Augenheilkunde, Dietrich-Bonhoeffer-Klinikum Neubrandenburg Germany
8 Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazio Catania Italy
9 Wojskowy Instytut Medyczny (Military Medical Institute) Warsaw Poland
10 Institut Catala de Retina Barcelona Spain
11 Instituto de Microcirugia Ocular Barcelona Spain
12 Hospital Clinico San Carlos Madrid Spain
13 Ramón y Cajal University Hospital Madrid Spain
14 Hospital Universiatrio Miguel Servet Zaragoza Spain

Sponsors and Collaborators

  • Transcend Medical, Inc.

Investigators

  • Study Director: Tsontcho (Sean) Ianchulev, MD, MPH, Transcend Medical, Inc.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Transcend Medical, Inc.
ClinicalTrials.gov Identifier:
NCT01097174
Other Study ID Numbers:
  • TMI-09-02
First Posted:
Apr 1, 2010
Last Update Posted:
May 15, 2017
Last Verified:
Oct 1, 2016
Keywords provided by Transcend Medical, Inc.
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 15, 2017